Pfizer gets EU approval for long-acting human growth hormone, softening blow of FDA rejection Targeting a $300M market, Almirall starts selling 'less greasy' psoriasis cream in the EU Modra, taking a leaf out of the Paxlovid playbook, validates oral delivery of chemotherapy in the clinic PolyActiva's glaucoma implant cuts pressure in clinical test, opening the door to further development Roche settles lawsuit claiming AstraZeneca's Ultomiris infringes delivery patent Featured Story | By Nick Paul Taylor Pfizer and Opko Health have bounced back from a FDA rejection to win approval for long-acting human growth hormone Ngenla in the EU, putting the pair hot on the heels of their rival Ascendis Pharma. read more |
| |
|---|
|
Top Stories By Nick Paul Taylor Almirall is about to learn whether its bet on topical plaque psoriasis cream Wynzora will pay off. Having acquired European rights to the product from MC2 Therapeutics last year, Almirall has now begun selling the drug in the U.K., Spain and Germany while preparing to enter other markets. read more By Nick Paul Taylor Modra Pharmaceuticals’ oral docetaxel has performed comparably to the intravenous incumbent in a phase 2b clinical trial, emboldening the company to start work on a pivotal study. read more By Nick Paul Taylor PolyActiva’s glaucoma implant has cleared an early clinical test. With the study linking the lowest dose of the biodegradable implant to improved outcomes, PolyActiva is preparing to move deeper into the clinic. read more By Angus Liu Roche has decided to close out a patent infringement lawsuit against AstraZeneca centering on the latter company's newly acquired rare disease drug Ultomiris. read more Resources Sponsored by: Catalent Learn more about how the versatility of Softgel Technology helped a customer with a volatile compound. Sponsored by: Catalent What is the most suitable dosage form technology for the Oral Delivery of Lipid-Based Formulations? Sponsored by: Catalent How can Lipid-Based Drug Delivery System help bring poorly soluble drugs to market? Sponsored by: Blue Matter What’s in store for the CNS therapeutics market in 2022? This paper looks ahead in Alzheimer’s, Parkinson’s, DMD, psychiatric disorders, pain, and more. Sponsored by: Catalent Biologics Ypsomed and Catalent Biologics experts discuss strategies for integrated PFS manufacturing and auto-injector assembly to accelerate timelines and more in this webinar. Sponsored by: Catalent Biologics Learn how formulation development for a PFS affects manufacturing to drive the industry toward optimizing delivery of injectable products and, ultimately, improving patient care. Virtual Healthcare Compliance Certificate February 28 - March 3, 2022 Fierce Drug Safety Summit March 8-9, 2022 | Virtual Webinar: Case Study in Clinical Toxicology March 9, 2022 1:00 PM ET Webinar: Data Visualization and Storytelling March 10, 2022 | 12:00 PM ET | University of Florida College of Pharmacy Fierce BD&L Summit for Life Sciences March 15-16, 2022 | San Francisco, CA Fierce Medical Affairs Strategic Summit (MASS East) April 12-14, 2022 | New Brunswick, NJ Fierce Promotional Review Committee Compliance and Best Practices Summit April 12-14, 2022 | New Brunswick, NJ Fierce Trial Master File Summit May 2-4, 2022 | New Orleans, LA & Streaming Live Fierce Leaders in Life Sciences Forum May 24, 2022 | Virtual Fierce Health IT Summit May 24, 2022 | Virtual Event Fierce Digital Pharma Engage June 14-15, 2022 | Huntington Beach, CA Fierce Pharma PR & Communications Summit West June 14-15, 2022 | Huntington Beach, CA Fierce Digital Pharma Innovation Week June 21-23, 2022 | Virtual Event Fierce Biotech Next Gen Week June 29-30, 2022 | Virtual Event Fierce Pharma PR & Communications Summit July 19-20, 2022 | Jersey City, NJ Fierce MedTech Summit August 8-9, 2022 | Minneapolis, MN Promotional Review Committee Compliance and Best Practices Summit West (PRC West) September 2022 | San Diego, CA Medical Affairs Strategic Summit (MASS West) September 2022 | San Diego, CA Fierce Biotech Summit September 13-14, 2022 | Boston, MA Fierce Digital Pharma East October 18-20, 2022 | Philadelphia, PA & October 25-28, 2022 | Virtual Event Fierce Pharma Marketing Awards October 19, 2022 | Philadelphia, PA Fierce Biotech Cell & Gene Therapy Forum October 19, 2022 | Virtual Event Fierce European Trial Master File Summit October 31- November 2, 2022 | London Fierce Pharma Meeting Professionals Summit November 2-3, 2022 | Atlantic City, NJ Fierce Diversity, Equity & Inclusion Forum November 15-16, 2022 | Virtual Event Drug Development Boot Camp® HYBRID/VIRTUAL November 16-17, 2022 Fierce Launch Readiness for Medical Affairs & Communications Teams Summit November 30-December 1, 2022 | Virtual Event Fierce New Product Planning Summit November 30 - December 1, 2022 | Boston, MA Fierce JPM Week 2023 January 2023 | San Francisco, CA & Virtual | 